714 related articles for article (PubMed ID: 30617281)
1. Rhabdomyosarcoma.
Skapek SX; Ferrari A; Gupta AA; Lupo PJ; Butler E; Shipley J; Barr FG; Hawkins DS
Nat Rev Dis Primers; 2019 Jan; 5(1):1. PubMed ID: 30617281
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
3. [Diagnosis and treatment of childhood soft tissue sarcomas].
Bánusz R; Váradi Z; Varga E; Jakab Z; Garami M; Csóka M
Magy Onkol; 2014 Mar; 58(1):59-64. PubMed ID: 24712008
[TBL] [Abstract][Full Text] [Related]
4. Anaplasia in childhood rhabdomyosarcoma: An under reported entity.
Ahuja M; Tomar R; Thakur S; Mallya V; Mandal S; Khurana N; Sarin YK
Indian J Pathol Microbiol; 2022; 65(4):864-868. PubMed ID: 36308195
[TBL] [Abstract][Full Text] [Related]
5. Role of surgery in children with rhabdomyosarcoma.
Schalow EL; Broecker BH
Med Pediatr Oncol; 2003 Jul; 41(1):1-6. PubMed ID: 12764734
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology of rhabdomyosarcoma.
Gallego Melcón S; Sánchez de Toledo Codina J
Clin Transl Oncol; 2007 Jul; 9(7):415-9. PubMed ID: 17652054
[TBL] [Abstract][Full Text] [Related]
7. Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma.
Harel M; Ferrer FA; Shapiro LH; Makari JH
Urol Oncol; 2016 Feb; 34(2):103-15. PubMed ID: 26519985
[TBL] [Abstract][Full Text] [Related]
8. Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis.
Allen-Rhoades W; Lupo PJ; Scheurer ME; Chi YY; Kuttesch JF; Venkatramani R; Meyer WH; Mascarenhas L
Cancer Med; 2023 May; 12(9):10222-10229. PubMed ID: 37016270
[TBL] [Abstract][Full Text] [Related]
9. Childhood rhabdomyosarcoma: new insight on biology and treatment.
Huh WW; Skapek SX
Curr Oncol Rep; 2010 Nov; 12(6):402-10. PubMed ID: 20820958
[TBL] [Abstract][Full Text] [Related]
10. Pleomorphic Rhabdomyosarcoma: A Systematic Review with Outcome Analysis and Report of a Rare Abdominal Wall Lesion.
Deb PQ; Chokshi RJ; Li S; Suster DI
Int J Surg Pathol; 2023 Aug; 31(5):548-556. PubMed ID: 35707991
[No Abstract] [Full Text] [Related]
11. Update on molecular findings in rhabdomyosarcoma.
El Demellawy D; McGowan-Jordan J; de Nanassy J; Chernetsova E; Nasr A
Pathology; 2017 Apr; 49(3):238-246. PubMed ID: 28256213
[TBL] [Abstract][Full Text] [Related]
12. The natural origins of cytostatic compounds used in rhabdomyosarcoma therapy.
Lewandowski D; Szewczyk A; Radzka J; Dubińska-Magiera M; Kazimierczak W; Daczewska M; Migocka-Patrzałek M
Adv Clin Exp Med; 2023 Oct; 32(10):1179-1191. PubMed ID: 36920267
[TBL] [Abstract][Full Text] [Related]
13. Rhabdomyosarcoma in children: Retrospective analysis from a single tertiary care center in Saudi Arabia.
Markiz SN; Khan S; Wagley ZB; Viqaruddin MK; Khafaga YM; AlFawaz IA; AlAnazi AE; AlKofide A; Khoja HA; Ali AA
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1683. PubMed ID: 35942988
[TBL] [Abstract][Full Text] [Related]
14. Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers.
Sartori F; Alaggio R; Zanazzo G; Garaventa A; Di Cataldo A; Carli M; Rosolen A;
Cancer; 2006 Apr; 106(8):1766-75. PubMed ID: 16544315
[TBL] [Abstract][Full Text] [Related]
15. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial.
Bisogno G; De Salvo GL; Bergeron C; Gallego Melcón S; Merks JH; Kelsey A; Martelli H; Minard-Colin V; Orbach D; Glosli H; Chisholm J; Casanova M; Zanetti I; Devalck C; Ben-Arush M; Mudry P; Ferman S; Jenney M; Ferrari A;
Lancet Oncol; 2019 Nov; 20(11):1566-1575. PubMed ID: 31562043
[TBL] [Abstract][Full Text] [Related]
16. Rhabdomyosarcoma.
Dasgupta R; Fuchs J; Rodeberg D
Semin Pediatr Surg; 2016 Oct; 25(5):276-283. PubMed ID: 27955730
[TBL] [Abstract][Full Text] [Related]
17. Soft tissue sarcoma in children: prognosis and management.
Koscielniak E; Morgan M; Treuner J
Paediatr Drugs; 2002; 4(1):21-8. PubMed ID: 11817983
[TBL] [Abstract][Full Text] [Related]
18. Rhabdomyosarcoma: current challenges and their implications for developing therapies.
Hettmer S; Li Z; Billin AN; Barr FG; Cornelison DD; Ehrlich AR; Guttridge DC; Hayes-Jordan A; Helman LJ; Houghton PJ; Khan J; Langenau DM; Linardic CM; Pal R; Partridge TA; Pavlath GK; Rota R; Schäfer BW; Shipley J; Stillman B; Wexler LH; Wagers AJ; Keller C
Cold Spring Harb Perspect Med; 2014 Nov; 4(11):a025650. PubMed ID: 25368019
[TBL] [Abstract][Full Text] [Related]
19. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
Yu L; Wang J
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
[TBL] [Abstract][Full Text] [Related]
20. NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma.
Tombolan L; Poli E; Martini P; Zin A; Romualdi C; Bisogno G; Lanfranchi G
Oncotarget; 2017 May; 8(20):33086-33099. PubMed ID: 28380437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]